logo
2 Search results with low strength
See also:Test guides (4)Algorithm (3)

496 - Hemoglobin A1c

To assist with control of blood glucose levels, the American Diabetes Association (ADA) has recommended glycated hemoglobin testing (HbA1c) twice a year for patients with stable glycemia, and quarterly for patients with poor glucose control. Interpretative ranges are based on ADA guidelines.

91304 - Pernicious Anemia Diagnostic Panel

This panel tests for anti-intrinsic factor antibodies, vitamin B12, and methylmalonic acid (MMA) and can be used to identify pernicious anemia as the cause of vitamin B12 deficiency. In patients with clinical suspicion of pernicious…
Not finding what you're looking for?

Showing all 2 results

Test guides (4)

Laboratory Testing for Diabetes Diagnosis, Risk Assessment, and Management

This test guide discusses the use of laboratory tests for general screening and diagnosis of prediabetes and diabetes; it also provides additional information on diabetes risk assessment and monitoring glycemic control and complications in individuals with diabetes.

New
Laboratory Testing for Chronic Kidney Disease Diagnosis and Management

This test guide provides an overview of tests used to detect chronic kidney disease (CKD) in adults, as well as monitor CKD progression, comorbidities, complications, and response to therapy.

Polycystic Ovary Syndrome (PCOS)

This Clinical Focus provides information on tests available for the differential diagnosis of polycystic ovary syndrome (PCOS) and the identification of common comorbidities.

Cardiometabolic Disease Assessment (CMDA) Panel

This panel is used to assess cardiometabolic dysfunction in the context of (1) early-stage measures of dyslipidemia and glycemic control, (2) common endocrine disorders, and (3) downstream adverse effects on end-organ dysfunction, including liver and kidney.

Showing all 4 results

Algorithms (3)

Suggested Use of the 1,5-AG Test

This algorithm provides a strategy for improving glucose control in patients with diabetes. Interpretive information for the 1,5-AG test is included.

Staging presymptomatic patients using Diabetes Type 1 Autoantibody Panel

This algorithm provides suggested use of laboratory tests to stage presymptomatic patients with suspected type 1 diabetes.

Testing for Comorbidities and Complications of Chronic Kidney Disease

This figure provides a description of testing for comorbidities and complications of chronic kidney disease.

Showing all 3 results

Quest, Quest Diagnostics, the associated logo, Nichols Institute and all associated Quest Diagnostics marks are the registered trademarks of Quest Diagnostics. All third party marks— ® and ™ — are the property of their respective owners. © 2000-2019 Quest Diagnostics Incorporated. All rights reserved.